Greetings from Golden Seeds | | |
As 2025 comes to a close, Golden Seeds is proud to celebrate another season of growth, impact, and opportunity. This past month marked an exciting milestone — the official launch of our ninth chapter, located in Chicago, expanding our reach into one of the nation’s most dynamic hubs for innovation and entrepreneurship.
With nearly 300 members across the country and internationally, Golden Seeds continues to advance its mission of funding and supporting exceptional women-led companies. From groundbreaking health tech innovations to sustainable solutions shaping the future, our members and portfolio companies continue to demonstrate the power of investing with purpose.
| | Golden Seeds companies are constantly making progress, shaking up established industries or breaking into new ones with their innovations. | | | | |
Three Golden Seeds companies featured in Time's best inventions of 2025
Golden Seeds companies, Kind Designs for their living seawalls, Osteoboost for their FDA-cleared drug-free prescription treatment for osteopenia in postmenopausal women, and UNCAGED Innovations for Elevate, a grain-based leather alternative, were named in Time's Best Inventions of 2025 list.
| | | | |
Concerto Biosciences announces positive topline results from Phase 1b clinical trial of ENS-002 in patients with atopic dermatitis
Golden Seeds company, Concerto Biosciences®, a clinical-stage biotech company developing microbial products for therapeutics and consumer markets, announced positive topline results from its first-in-human Phase 1b clinical trial evaluating ENS-002, a topical three-strain live biotherapeutic product for mild-to-moderate atopic dermatitis.
| | | | |
National Kidney Foundation's Innovation Fund invests in BMI OrganBank to advance breakthrough kidney transplant technology
Golden Seeds company, BMI OrganBank, is a medical device company pioneering next-generation organ preservation and assessment technologies. The funding will be used to finalize preparations for BMI OrganBank's upcoming clinical study of its room temperature machine perfusion platform, designed to improve kidney transplant outcomes and reduce waitlist times for patients.
| | Recent Investment Highlights | | | | |
RCOAST is building the world’s first AI-powered library of coastal protection. It uses drones, satellites, and environmental data to measure how mitigation strategies perform through storms and seasonal change. Its AI learns from this continuous data to predict which solutions work best for any shoreline facing erosion.
The result is a platform that gives communities, engineers, and insurers clear, data-driven answers to invest in the most effective coastal defenses. RCOAST is transforming fragmented coastal data into the intelligence engine powering global resilience.
| | | | |
Bairitone removes the guesswork from sleep apnea diagnosis with an AI-powered wearable that captures detailed patient anatomy at home. Its sonar-based technology provides sleep care providers the same insights as invasive procedures like drug-induced sleep endoscopy (DISE) without the cost, risk, or inconvenience.
As a platform technology for non-invasive imaging, Bairitone has the potential to expand beyond sleep care. By making accurate, non-invasive diagnostics accessible, it reduces unnecessary imaging, improves patient outcomes, and streamlines clinical workflows.
| | | | |
Golden Seeds launches ninth chapter, located in Chicago
Chicago Inno by Chicago Business Journal recently featured the creation of our ninth chapter in their article, “Golden Seeds angel network opens Chicago chapter to boost women-led startups.”
The new Chicago chapter, led by Managing Directors Susan Abrams, Angela Allen, and Linda Singh, marks an exciting milestone in our mission to improve access to capital for women-led startups across the country.
| | At nearly 300 members, Golden Seeds’ angel investors, along with its funds, have invested over $190 million in early-stage women-led companies. On January 9th and February 6th, you’ll have the chance to learn how you can do the same. Join us for our Open House and learn how you can become part of our growing community of like-minded investors who are changing the landscape of angel investing. | | |
Friday, January 9th, 2025
1PM ET / 10AM PT
| |  | |
Friday, February 6th, 2025
1PM ET / 10AM PT
| | Golden Seeds believes that knowledge is the cornerstone of successful investing. That’s why we want to share what we know about angel investing with you. Join us for an upcoming course on how to conduct due diligence, boards and governance training, or an industry sector deep dive. Four of our upcoming courses are listed below. See all of our upcoming courses. |
| |
Health Care Sector Training: Therapeutics
December 2nd, 2025 at 1:00 PM - 2:30 PM ET
| | | |
Health Care Sector Training: Devices & Diagnostics
December 8th, 2025 at 1:00 PM - 3:00 PM ET
| | | |
Introduction to Angel Investing
January 12th, 2026 at 12:00 PM - 2:00 PM ET
| | | |
Due Diligence Process Training
January 22nd, 2025 at 1:00 PM - 4:00 PM ET
| | | | | First get an understanding of our investment criteria | | | | Join an Information Session - learn more about the basics of angel funding | | | | Attend an Office Hours - an unstructured conversation with Golden Seeds investors about your business | | |
About Golden Seeds
For over 20 years, Golden Seeds has been a leader in funding promising women-led companies. Headquartered in New York City, with active chapters in Arizona, Atlanta, Boston, Chicago, Dallas, Houston, New Jersey, New York, and Silicon Valley, Golden Seeds is one of the largest angel networks in the United States with nearly 300 members. In total, Golden Seeds’ members and funds have invested over $190 million in more than 260 companies.
| | If you found this newsletter helpful, share it | | | | |
